anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 27,451-27,480
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

27,451-27,480 of 43,093

filter-aware
27
Includes footnotes explaining IRR calculation methodology and fund-specific exclusions.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
28
The slide presents a detailed breakdown of assets for Apollo's two primary business segments.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
29
Financial data table showing liabilities and equity breakdown for Apollo Global Management.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
30
Includes detailed footnotes explaining specific adjustments.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
31
Includes extensive footnotes explaining specific adjustments for Asset Management and Retirement Services segments.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
32
Contains four distinct sub-tables detailing investment components, performance fee receivables, and gross/net invested assets.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
33
The table shows adjustments for investment gains/losses, insurance liabilities, integration expenses, stock compensation, and non-controlling interests.Apollo Global Management | Results Presentation Deck | 40 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
01
Slide 1
AstraZeneca | Results Presentation Deck | 157 slidesAstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
02
The slide uses a grid layout to present four key performance indicators related to the drug development pipeline.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
03
The slide uses a matrix-like layout to categorize events by time period and event type (regulatory vs. data readout).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
04
The slide uses a matrix-like layout to organize drug assets by therapeutic area and development stage (approved vs. pipeline).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
05
The slide uses a four-column layout to track drug development progress.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
06
The slide tracks changes in drug development pipeline status since the Q2 2024 update.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
07
The slide uses a grid-based layout to list specific drug assets and their indications within each phase column.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
08
The slide uses a grid-based layout to represent the drug development pipeline.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
09
The slide uses a grid-based layout to organize drug candidates by development stage. It includes a legend for '# Partnered and/or in collaboration' and a yellow dot for 'Precision medicine approach being explored'.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
10
The slide uses a timeline-like structure to categorize drug development projects by clinical phase.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a Kanban-style board to visualize drug development stages.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a color-coded system to distinguish between Oncology, Biopharmaceuticals, and Rare Disease designations.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
AstraZeneca | Results Presentation Deck | 157 slidesAstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a color-coded sidebar to indicate the development stage of the drug across different therapeutic areas.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide provides a detailed overview of seven specific clinical trials (AEGEAN, ADJUVANT BR.31, PACIFIC-4, PACIFIC-5, PACIFIC-8, ADRIATIC, PACIFIC-9).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide is part of an appendix, providing detailed clinical trial data for Imfinzi.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide is part of an appendix section detailing clinical trial status for specific drug assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide is part of an appendix, likely from a pharmaceutical investor presentation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a vertical tab structure on the right to categorize the therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
22
The slide provides a structured overview of three specific clinical trials: DESTINY-Gastric04, 06, and 03.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
23
The slide is part of an appendix, indicated by the footer and the 'Other' tab in the right-hand navigation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit